Here are five key notes:
1. In the last four weeks, Smith & Nephew shares dropped 5.83 percent, but they’re still only marginally negative compared with the S&P 500 for this past week, according to the report.
2. Smith & Nephew shares underperformed the index by 6.55 percent over the past four years.
3. The report cautions investors to watch for additional “signals and trade” cautiously.
4. In the past month, Smith & Nephew reported a negative 49.37 percent change in short interest.
5. The average trading volume in the past 20 trading days is 516,098.
More articles on orthopedic devices:
Lumin Health names two new executives
Medtronic, LDR, Smith & Nephew & more—25 key notes
5 key trends in the global bio-implants market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
